Date published: 2025-9-5

1-800-457-3801

SCBT Portrait Logo
Seach Input

Ibutilide Fumarate (CAS 122647-32-9)

0.0(0)
Write a reviewAsk a question

Application:
Ibutilide Fumarate is a sodium channel protein inhibitor
CAS Number:
122647-32-9
Purity:
≥99%
Molecular Weight:
442.61
Molecular Formula:
C22H38N2O5S
For Research Use Only. Not Intended for Diagnostic or Therapeutic Use.
* Refer to Certificate of Analysis for lot specific data.

QUICK LINKS

Ibutilide fumarate is a class III antiarrhythmic agent that functions as a selective blocker of the rapid component of the delayed rectifier potassium current in cardiac cells. It exerts its mechanism of action by prolonging the action potential duration and refractory period in atrial and ventricular myocardial cells, leading to the inhibition of potassium channels. This results in the prolongation of the effective refractory period in atrial and ventricular muscle and the reduction of the action potential duration. Ibutilide fumarate′s mechanism of action involves the activation of slow inward sodium current, which leads to the depolarization of the membrane potential and the initiation of action potentials. It may increase intracellular calcium levels, which may contribute to its antiarrhythmic effects. Ibutilide fumarate′s mechanism of action involves the modulation of ion channels and intracellular calcium levels in cardiac cells, leading to alterations in action potential duration and refractory period.


Ibutilide Fumarate (CAS 122647-32-9) References

  1. Pharmacological atrial defibrillation via temporarily occluded coronary sinus: first clinical experience and implications for an implantable device.  |  Vergara, G., et al. 2000. J Interv Card Electrophysiol. 4: 345-9. PMID: 10936000
  2. Effects of sodium channel blockade on ibutilide induced prolongation of repolarization in the isolated rabbit ventricle.  |  Wood, MA., et al. 2000. J Interv Card Electrophysiol. 4: 481-7. PMID: 11046186
  3. Frequency-dependent electrophysiological effect of ibutilide on human atrium and ventricle.  |  Oshikawa, N., et al. 2001. J Interv Card Electrophysiol. 5: 81-7. PMID: 11248779
  4. N-[(omega-amino-1-hydroxyalkyl)phenyl]methanesulfonamide derivatives with class III antiarrhythmic activity.  |  Hester, JB., et al. 1991. J Med Chem. 34: 308-15. PMID: 1992131
  5. Assay of the enantiomers of ibutilide and artilide using solid-phase extraction, derivatization, and achiral-chiral column-switching high-performance liquid chromatography.  |  Hsu, CL. and Walters, RR. 1995. J Chromatogr B Biomed Appl. 667: 115-28. PMID: 7663674
  6. Ibutilide.  |  . 1996. Med Lett Drugs Ther. 38: 38. PMID: 8606678
  7. Pharmacokinetics of ibutilide and its enantiomers in dogs.  |  Hsu, CY. and Walters, RR. 1996. Chirality. 8: 18-23. PMID: 8845277
  8. Antiarrhythmic and electrophysiologic effects of intravenous ibutilide and sotalol in the canine sterile pericarditis model.  |  Buchanan, LV., et al. 1996. J Cardiovasc Electrophysiol. 7: 113-9. PMID: 8853021
  9. Electrophysiology and pharmacology of ibutilide.  |  Naccarelli, GV., et al. 1996. Am J Cardiol. 78: 12-6. PMID: 8903270
  10. Efficacy of ibutilide for termination of atrial fibrillation and flutter.  |  Ellenbogen, KA., et al. 1996. Am J Cardiol. 78: 42-5. PMID: 8903275
  11. Developmental toxicity of ibutilide fumarate in rats after oral administration.  |  Marks, TA. and Terry, RD. 1996. Teratology. 54: 157-64. PMID: 8987159
  12. Ibutilide: a new class III antiarrhythmic agent.  |  Cropp, JS., et al. 1997. Pharmacotherapy. 17: 1-9. PMID: 9017761
  13. Erythematous bullous lesions on the dorsa of the hands due to contact exposure to ibutilide fumarate for injection.  |  Dodds, ES. and Oberg, KC. 1998. Pharmacotherapy. 18: 880-2. PMID: 9692669

Ordering Information

Product NameCatalog #UNITPriceQtyFAVORITES

Ibutilide Fumarate, 10 mg

sc-211627
10 mg
$250.00